PROFESSIONAL INSIGHTS INTO PACEMAKER AND ICD THERAPY: FUNCTION, MANAGEMENT, AND BEST PRACTICES

Cardiac device therapy, encompassing permanent pacemakers and Implantable Cardioverter Defibrillators (ICDs), represents a cornerstone in managing serious cardiac rhythm disorders. These devices are essential for restoring electrical stability, maintaining adequate cardiac output, and ultimately preventing sudden cardiac death (SCD).

Functions of the Permanent Pacemaker

A permanent pacemaker is an electronic device designed to treat symptomatic bradyarrhythmias (slow heart rates) by providing electrical stimuli to the heart muscle when the heart’s intrinsic electrical rate falls below a preset threshold. The function of a modern pacemaker is summarized by three essential tasks:

1. Sensing

The pacemaker must monitor the heart’s intrinsic electrical activity. Good sensing ensures the device only delivers pacing pulses when necessary, preventing competition between the device and the native heart rhythm. Over-sensing (misinterpreting noise as a native beat) or under-sensing (failing to recognize a native beat) can lead to inappropriate pacing.

2. Pacing

When the intrinsic rate falls below the programmed lower rate limit, the pacing circuit generates a small electrical impulse (pacing spike) to depolarize the myocardial tissue. This restores a stable heart rate and rhythm.

3. Capture

Capture is the heart’s successful response to the electrical impulse, resulting in myocardial depolarization and contraction. The nurse verifies capture by observing a corresponding QRS complex on the electrocardiogram (ECG) following the pacing spike and palpable peripheral pulse.

Pacemaker Code (NBG System)

Pacemaker functionality is universally described by the NBG (North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group) five-letter code. The first three positions are most critical:

Comparing Pacemaker Types, Indications, Complications, and Nursing Interventions

Pacemakers are categorized based on the number of heart chambers they stimulate. The choice of device is dictated by the specific underlying arrhythmia and clinical presentation.

Common Complications of Pacemaker Implantation

Acute Complications (First 24-48 hours):

1. Pneumothorax: Resulting from accidental puncture of the pleura during subclavian vein access.
2. Lead Dislodgement: Leads can move out of their intended position, causing loss of capture or inappropriate sensing. Leads to battery dependence or symptomatic bradycardia.
3. Pocket Hematoma/Bleeding: Bleeding at the insertion site, often exacerbated by anticoagulants.
4. Pericardial Effusion/Tamponade (Rare): Lead perforation of the myocardium.

Chronic Complications (Weeks to Years):

1. Infection: Pocket infection or systemic endocarditis on the lead structures. Requires device explantation and prolonged antibiotics.
2. Premature Battery Depletion: Due to prolonged, high-output pacing settings.
3. Pacemaker Syndrome: Symptomatic hypotension, fatigue, and weakness caused by loss of AV synchrony (usually seen with VVI pacing).

Nursing Interventions for Pacemaker Clients

Purpose of the Implantable Cardioverter Defibrillator (ICD)

The ICD is a specialized device designed primarily to prevent sudden cardiac death (SCD) caused by malignant ventricular tachyarrhythmias—Ventricular Tachycardia (VT) and Ventricular Fibrillation (VF). Unlike a pacemaker, which treats slow rhythms, the ICD’s main role is to terminate fast, life-threatening rhythms.

ICD Mechanism

The ICD operates in a highly sophisticated manner:

1. Sensing: The ICD continuously monitors the heart rhythm.
2. Detection: If the device detects a rate within the pre-programmed VT/VF zones, it initiates therapy.
3. Therapy Delivery:
   • Antitachycardia Pacing (ATP): For stable VT, the ICD may first deliver a rapid, short burst of pacing pulses to interrupt the re-entrant electrical circuit, often terminating the arrhythmia without a painful shock.
   • High-Energy Defibrillation Shock: If ATP fails or if the rhythm is immediate VF, the ICD charges and delivers a high-energy electrical shock (typically 25–40 Joules) to defibrillate the heart, restoring a perfusing rhythm (Epstein et al., 2017).

Primary Indications for ICD Implantation

ICDs are indicated for both primary prevention (Pacing in individuals without a history of SCD but at high risk) and secondary prevention (in those who have already survived SCD).

Secondary Prevention:

• Survivors of cardiac arrest due to VT or VF (if reversible causes were ruled out).
• Sustained VT resulting in hemodynamic instability.

Primary Prevention (High-Risk Groups):

• Coronary Artery Disease (CAD) patients with severely reduced Left Ventricular Ejection Fraction (LVEF $\le$ 35%) post-myocardial infarction.
• Non-ischemic cardiomyopathy with LVEF $\le$ 35%.
• Certain inherited arrhythmia syndromes (e.g., Long QT syndrome, Brugada syndrome) (Al-Khatib et al., 2017).

Nursing Management of Clients with an Implantable Cardioverter Defibrillator

Nursing management for ICD clients includes all the standard pacemaker interventions (related to pacing, incision care, and lead stability) but adds critical responsibilities related to patient education, psychological support, and post-shock care.

A. Post-Procedure Monitoring and Education

1. Device Function Monitoring: Ensure continuous telemetry monitoring. After implantation, the ICD is typically “shock-enabled” after confirmation of lead position and successful rhythm induction/defibrillation testing in the operating room. Monitor for inappropriate shocking (e.g., shocking due to supraventricular tachycardia misinterpreted as VT).
2. Psychosocial Support: Clients often harbor significant anxiety (“shock anxiety”) and fear about the device delivering a painful discharge. Nurses must normalize these feelings, explain that the device is a protective tool, and encourage support group participation.
3. Driving Restrictions: This is a crucial teaching point. Patients with a known history of VT/VF (secondary prevention) or those who have recently received an appropriate shock must cease driving for a defined period (often 6 months) until deemed stable and shock-free by the physician (ACC/AHA/HRS guidelines).

B. Post-Shock Management

1. If the client receives a shock:
   • Single Shock: If the client feels well, they should contact the cardiology clinic immediately for device interrogation.
   • Multiple Shocks (ICD Storm): If the client receives multiple shocks in rapid succession and feels unwell, they must call EMS immediately. This is a medical emergency requiring hospitalization and identification of the underlying trigger (e.g., ischemia, electrolyte imbalance).
2. Assessment: If a shock occurs, the nurse must assess the patient’s hemodynamic stability, level of consciousness, and chest pain. A shock indicates that a life-threatening arrhythmia occurred.
3. Data Retrieval: The ICD stores detailed electrograms (EGMs) of the rhythm that triggered the therapy. Interrogation allows the physician to confirm if the shock was appropriate (for VT/VF) or inappropriate (for noise/SVT) (Epstein et al., 2017).

C. Electromagnetic Interference (EMI) and Safety Teaching

ICD devices are more sensitive to strong magnetic fields than pacemakers. Patients must:

• Avoid placing cell phones directly over the device.
• Maintain a distance of 6–12 inches from strong magnets (e.g., speakers, industrial equipment).
• Inform all healthcare providers (including dentists) about the ICD, as procedures involving diathermy, high-frequency radiation, or focused high-energy magnetic fields are contraindicated or require temporary deactivation (magnet placement over the pocket).

Conclusion

Pacemaker therapy and ICDs are indispensable tools in modern electrophysiology. The pacemaker ensures adequate heart rate and AV synchrony, while the ICD provides a critical safety mechanism against sudden cardiac death. Nurses play a foundational role in the success of these therapies, ensuring meticulous post-operative monitoring, anticipating and managing potential complications, and delivering comprehensive, individualized patient education to maximize compliance and improve quality of life.

References

Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., et al. (2017). 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Circulation, 138(13), e272–e391.

Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., et al. (2017). ACC/AHA/HRS 2017 Performance Measures for Electrophysiology Procedures. Heart Rhythm, 14(11), e341–e360.

Kusumoto, F. M., Calkins, H., Chung, M. K., et al. (2019). 2019 ACC/AHA/HRS Focused Update of the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay. Circulation, 141(1), e40–e104.